Canaan Partners XI LLC
Follow13F filer, CIK 1850694, MENLO PARK, CA
Canaan Partners XI LLC reported $77,290,724 across 3 holdings for the quarter ended 2024-12-31, in a 13F-HR filed 2025-01-21.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-25-000423
- Period
- 2024-12-31
- Reported value
- $77.3M
- Holdings
- 3
- Top 10 weight
- 100%
- New
- 0
- Sold out
- 0
Largest buys vs the previous quarter
None.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| TYRAreduced | -230,134 | -$3.2M |
| RALLYBIO CORPreduced | -213,303 | -$205K |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q4 2024
Share positions as resolved from 13F-HR 0000950123-25-000423, largest first. % of portfolio is the value over $77,290,724, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| TYRATYRA BIOSCIENCES INC | 4,179,857 | $58.1M | 75.17% | -230,134 | Timeline | ||
| AEVAAEVA TECHNOLOGIES INC | 3,697,039 | $17.6M | 22.72% | 0 | Timeline | ||
| RALLYBIO CORPRALLYBIO CORP | 1,697,684 | $1.63M | 2.11% | -213,303 |
How Q4 2024 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0000950123-25-000423 | base | 2025-01-21 | acceptance time not in the bulk data set |